Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

I think you are misreading the intended meaning. The intended meaning, it has collectively demonstrated those properties through phase 2 clinical testing, also collectively. The IBD pill is mentioned because there was a bridge study that included looking for markers for those 3 properties. Bridge studies confirm there are no changes in properties among possible delivery systems, so they “bridge” other advanced studies to new versions of a drug. Thus, Brilicidin phase 2 properties “bridge” to the new delivery. Is further clinical proof needed, yes. Are previous studies collectively assessed, again yes.

The drug is now at a Regional Biocontainment Center to see if it is worthy of advancing to clinical testing. In fact, because the US is now under a pandemic threat emergency, and Brilicidin has proven safety in humans, it’s likely it will be tested directly on covid-19 patients. The CDC has been doing this type of testing on the repatriated American coronavirus patients in California, according to yesterday’s NYTimes.

Seems those at NIAID and the CDC are not as nit-picky about collective data as many posters on stock blogs.